Royal Caribbean Cruises sell BiotechBee
Start price
21.09.22
/
70%
€47.73
Target price
31.12.24
€39.00
Performance (%)
-2.79%
End price
02.01.23
€46.40
Summary
This prediction ended on 02.01.23 with a price of €46.40. With a performance of -2.79%, the SELL prediction for Royal Caribbean Cruises by BiotechBee was down slightly. BiotechBee has 70% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Royal Caribbean Cruises | -6.956% | -6.956% | 52.436% |
iShares Core DAX® | 0.039% | 0.567% | 12.281% |
iShares Nasdaq 100 | -4.018% | -5.554% | 23.851% |
iShares Nikkei 225® | -2.389% | -1.434% | 8.335% |
iShares S&P 500 | -2.115% | -2.351% | 22.061% |
According to BiotechBee what are the pros and cons of Royal Caribbean Cruises for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by BiotechBee for this prediction
In the thread Royal Caribbean Cruises diskutieren
Sell mit Kursziel 39,0
In the thread Trading Royal Caribbean Cruises
Sell beendet